ArticleFrontiers in endocrinology2022

The selective aldosterone synthase inhibitor Baxdrostat significantly lowers blood pressure in patients with resistant hypertension.

Imma Forzano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.